Product Overview
• Co-amoxiclav (Amoxicillin 500 mg + Clavulanic acid 125 mg) film-coated tablets • Broad-spectrum beta-lactamase-resistant penicillin antibiotic • Effective for respiratory, urinary, skin, and dental infections • Prescription-only medicine • Pack contains 20 tablets (2 blister strips of 10)
Product Description
Klavox 625 mg Tablets combine amoxicillin (a penicillin antibiotic) with clavulanic acid (a beta-lactamase inhibitor) to provide enhanced coverage against resistant bacteria. Indicated for upper and lower respiratory tract infections (sinusitis, otitis media, pneumonia), urinary tract infections, skin/soft tissue infections, dental abscesses, and other bacterial infections where resistance to amoxicillin alone is suspected. The 625 mg strength allows convenient twice- or thrice-daily dosing with high efficacy. Benefits • Overcomes bacterial resistance – works when plain amoxicillin fails • Broad coverage including many Staph, Strep, H. influenzae, and E. coli strains • High success rates in common community-acquired infections • Twice- or thrice-daily dosing • Well tolerated with food to reduce stomach upset • Proven alternative to augmentin in many guidelines How to Use • Adults and children >40 kg: 1 tablet every 8–12 hours (2–3 times daily) • Severe infections: 1 tablet three times daily • Swallow whole with water – best taken at the start of a meal • Complete the full course (usually 5–14 days) even if symptoms improve • Drink plenty of fluids • Not suitable if allergic to penicillin or history of cholestatic jaundice with co-amoxiclav